Literature DB >> 11410791

Cycloprodigiosin hydrochloride, a H+/Cl- symporter, induces apoptosis in human colon cancer cell lines in vitro.

C Yamamoto1, H Takemoto, K Kuno, D Yamamoto, K Nakai, T Baden, K Kamata, H Hirata, T Watanabe, K Inoue.   

Abstract

Recently, we reported that cycloprodigiosin hydrochloride (cPrG.HCl), a novel H+/Cl- symporter, induces acidification of the cytosol and leads to apoptosis on rat and human liver cancer cells. In the present study, the effects of cPrG.HCl, a H+/Cl- symporter, were examined in colon cancer cell lines in vitro. In the MTT assay, cPrG.HCl inhibited the growth of two colon cancer cell lines (WiDr and SW480) in a dose- and time-dependent manner. The cPrG.HCl treatment of both types of cells induced apoptosis as confirmed by the appearance of a sub-G1 population and intranucleosomal DNA fragmentation. In addition, cPrG.HCl lowered pHi (below pH 6.8) respectively. Therefore, these results suggest that cPrG.HCl may be useful for the treatment of colon cancer cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410791     DOI: 10.3892/or.8.4.821

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

Review 1.  Mechanism targeted discovery of antitumor marine natural products.

Authors:  Dale G Nagle; Yu-Dong Zhou; Flor D Mora; Kaleem A Mohammed; Yong-Pil Kim
Journal:  Curr Med Chem       Date:  2004-07       Impact factor: 4.530

2.  Undecylprodigiosin induced apoptosis in P388 cancer cells is associated with its binding to ribosome.

Authors:  Ping Liu; Yuan-yuan Wang; Xin Qi; QianQun Gu; Meiyu Geng; Jing Li
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

Review 3.  Marine bioactives: pharmacological properties and potential applications against inflammatory diseases.

Authors:  Nicolantonio D'Orazio; Maria Alessandra Gammone; Eugenio Gemello; Massimo De Girolamo; Salvatore Cusenza; Graziano Riccioni
Journal:  Mar Drugs       Date:  2012-04-05       Impact factor: 6.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.